The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Lactate promotes glutamine uptake and metabolism in oxidative cancer cells
Open accessAbstract
Oxygenated cancer cells have a high metabolic plasticity as they can use glucose, glutamine and lactate as main substrates to support their bioenergetic and biosynthetic activities. Metabolic optimization requires integration. While glycolysis and glutaminolysis can cooperate to support cellular proliferation, oxidative lactate metabolism opposes glycolysis in oxidative cancer cells engaged in a symbiotic relation with their hypoxic/glycolytic neighbors. However, little is known concerning the relationship between oxidative lactate metabolism and glutamine metabolism. Using SiHa and HeLa human cancer cells, this study reports that intracellular lactate signaling promotes glutamine uptake and metabolism in oxidative cancer cells. It depends on the uptake of extracellular lactate by monocarboxylate transporter 1 (MCT1). Lactate first stabilizes hypoxia-inducible factor-2α (HIF-2α), and HIF-2α then transactivates c-Myc in a pathway that mimics a response to hypoxia. Consequently, lactate-induced c-Myc activation triggers the expression of glutamine transporter ASCT2 and of glutaminase 1 (GLS1), resulting in improved glutamine uptake and catabolism. Elucidation of this metabolic dependence could be of therapeutic interest. First, inhibitors of lactate uptake targeting MCT1 are currently entering clinical trials. They have the potential to indirectly repress glutaminolysis. Second, in oxidative cancer cells, resistance to glutaminolysis inhibition could arise from compensation by oxidative lactate metabolism and increased lactate signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It has long been established that Myc activation upregulates glutamine metabolism [79,80], increasing glutamine flux by upregulating the glutamine transporter (ASCT2) and glutaminase-1, thus increasing glutamine conversion to glutamate [81].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [81]
In the citing paper
“In addition, extracellular lactate stabilizes HIF-2α, and HIF-2α then transactivates MYC, increasing the levels of glutamine transporters and GLS1, in turn resulting in increased glutamine catabolism72.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Direct observation of individual endogenous protein complexes in situ by proximity ligation
Söderberg, O., Gullberg, M., Jarvius, M., Ridderstråle, K., Leuchowius, K.-J., Jarvius, J., Wester, K., Hydbring, P., Bahram, F., Larsson, L.-G., et al. (2006) · Nature Methods · doi:10.1038/nmeth947 · Cited by 2,419
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Sonveaux, P., Végran, F., Schroeder, T., Wergin, M., Verrax, J., Rabbani, Z. N., Saedeleer, C. J. D., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,635
Self-citation
Research works printed but not linked: 2
- Sowter HM, 2003, Cancer Res, 63, 6130
- Russell RR, 1991, Am J Physiol, 261, H1756
Cited by
Sorted by citations
From Krebs to clinic: glutamine metabolism to cancer therapy
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119
The Science and Translation of Lactate Shuttle Theory
Brooks, G. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.008 · Cited by 1,486
Metabolic Instruction of Immunity
Buck, M. D., Sowell, R., Kaech, S. M., & Pearce, E. L. (2017) · Cell · doi:10.1016/j.cell.2017.04.004 · Cited by 1,270
Glutamine reliance in cell metabolism
Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021
Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
de la Cruz-López, K. G., Castro-Muñoz, L. J., Reyes-Hernández, D. O., García-Carrancá, A., & Manzo-Merino, J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01143 · Cited by 940
“Lactate-induced c-MYC activation triggers the expression of the glutamine transporter ASCT2 and glutaminase 1 (GLS1), both resulting in improved glutamine uptake and catabolism (59).”
BackgroundGlutaminolysis: A Hallmark of Cancer Metabolism
Yang, L., Venneti, S., & Nagrath, D. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044546 · Cited by 859
Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
Li, X., Wenes, M., Romero, P. J., Huang, S. C., Fendt, S., & Ho, P. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0203-7 · Cited by 750
Monocarboxylate transporters in cancer
Payen, V. L., Mina, E., Hée, V. F. V., Porporato, P. E., & Sonveaux, P. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.07.006 · Cited by 688
Self-citationSan-Millán, I., & Brooks, G. A. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw127 · Cited by 640
Eelen, G., de Zeeuw, P., Treps, L., Harjes, U., Wong, B. W., & Carmeliet, P. (2017) · Physiological Reviews · doi:10.1152/physrev.00001.2017 · Cited by 614
Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets
Park, J. H., Pyun, W. Y., & Park, H. W. (2020) · Cells · doi:10.3390/cells9102308 · Cited by 571
Lactate: A Metabolic Driver in the Tumour Landscape
Ippolito, L., Morandi, A., Giannoni, E., & Chiarugi, P. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.10.011 · Cited by 541
Brown, T., & Ganapathy, V. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107451 · Cited by 518
Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
Jin, H.-R., Wang, J., Wang, Z., Xi, M., Xia, B., Deng, K., & Yang, J. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01498-2 · Cited by 537
Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity
Wang, J. X., Choi, S. Y. C., Niu, X., Kang, N., Xue, H., Killam, J., & Wang, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218363 · Cited by 460
Tumor glycolysis, an essential sweet tooth of tumor cells
Paul, S., Ghosh, S., & Kumar, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.09.007 · Cited by 449
Metabolism of Amino Acids in Cancer
Wei, Z. C., Liu, X., Cheng, C., Yu, W., & Yi, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.603837 · Cited by 456
Immunologic tumor microenvironment modulators for turning cold tumors hot
Khosravi, G. R., Mostafavi, S., Bastan, S., Ebrahimi, N., Gharibvand, R. S., & Eskandari, N. (2024) · 癌症：英文版 · doi:10.1002/cac2.12539 · Cited by 403
The Warburg Effect 97 Years after Its Discovery
Pascale, R. M., Calvisi, D. F., Simile, M. M., Feo, C. F., & Feo, F. (2020) · Cancers · doi:10.3390/cancers12102819 · Cited by 311
STAT proteins in cancer: orchestration of metabolism
Li, Y., Zhang, C., Martincuks, A., Herrmann, A., & Yu, H. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-022-00537-3 · Cited by 305
Cancer cell and macrophage cross-talk in the tumor microenvironment
Dehne, N., Mora, J., Namgaladze, D., Weigert, A., & Brüne, B. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.04.007 · Cited by 270
The Human SLC1A5 (ASCT2) Amino Acid Transporter: From Function to Structure and Role in Cell Biology
Scalise, M., Pochini, L., Console, L., Losso, M. A., & Indiveri, C. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00096 · Cited by 276
Short‐Chain Fatty Acid Transporters: Role in Colonic Homeostasis
Sivaprakasam, S., Bhutia, Y. D., Yang, S., & Ganapathy, V. (2017) · Comprehensive physiology · doi:10.1002/cphy.c170014 · Cited by 331
Allen, E., Miéville, P., Warren, C. M., Saghafinia, S., Li, L., Peng, M.-W., & Hanahan, D. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.029 · Cited by 221
Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy
Gupta, S., Roy, A., & Dwarakanath, B. S. R. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00068 · Cited by 225
Cancer metabolism in space and time: Beyond the Warburg effect
Danhier, P., Bański, P., Payen, V. L., Grasso, D., Ippolito, L., Sonveaux, P., & Porporato, P. E. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.02.001 · Cited by 230
Self-citationGoetzman, E. S., & Prochownik, E. V. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00129 · Cited by 199
Metabolism in Pulmonary Hypertension
Xu, W., Janocha, A. J., & ERZURUM, S. C. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031620-123956 · Cited by 194
Nicolini, A., & Ferrari, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1353787 · Cited by 209
The Metabolic Mechanisms of Breast Cancer Metastasis
Wang, L., Zhang, S., & Wang, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.602416 · Cited by 200
Metabolic heterogeneity in cancer
Demicco, M., Liu, X., Leithner, K., & Fendt, S. (2024) · Nature Metabolism · doi:10.1038/s42255-023-00963-z · Cited by 186
Linking metabolic reprogramming to therapy resistance in cancer
Morandi, A., & Indraccolo, S. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.12.004 · Cited by 184
Tumor acidity: From hallmark of cancer to target of treatment
Bogdanov, A. A., Bogdanov, A., Chubenko, V. A., Volkov, N., Moiseenko, F. V., & Moiseyenko, V. M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.979154 · Cited by 187
Microbial carcinogenesis: Lactic acid bacteria in gastric cancer
Vinasco, K., Mitchell, H. M., Kaakoush, N. O., & Castaño‐Rodríguez, N. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.07.004 · Cited by 176
HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells
Lee, S.-H., Golinska, M., & Griffiths, J. R. (2021) · Cells · doi:10.3390/cells10092371 · Cited by 169
Metabolic reprogramming, sensing, and cancer therapy
Mao, Y., Xia, Z., Xia, W., & Jiang, P. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115064 · Cited by 180
Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment
Zhang, H., Li, S., Wang, D., Liu, S. M., Xiao, T., Gu, W., Yang, H., Wang, H. Z., Yang, M., & Chen, P. (2024) · Biomarker Research · doi:10.1186/s40364-024-00646-1 · Cited by 178
Lactate Beyond a Waste Metabolite: Metabolic Affairs and Signaling in Malignancy
Baltazar, F., Afonso, J., Costa, M. F., & Granja, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00231 · Cited by 165
The crosstalk between HIFs and mitochondrial dysfunctions in cancer development
Bao, X., Zhang, J., Huang, G., Yan, J., Xu, C., Dou, Z., Sun, C., & Zhang, H. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03505-1 · Cited by 152
Woolf, E. C., Syed, N., & Scheck, A. C. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00122 · Cited by 126
Payen, V. L., Hsu, M. Y., Rädecke, K. S., Wyart, E., Vazeille, T., Bouzin, C., Porporato, P. E., & Sonveaux, P. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0764 · Cited by 120
Self-citationGLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma
Sun, H.-W., Yu, X.-J., Wu, W., Chen, J., Shi, M., Zheng, L., & Xu, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168907 · Cited by 121
Normalizing Tumor Vasculature to Reduce Hypoxia, Enhance Perfusion, and Optimize Therapy Uptake
Matuszewska, K., Pereira, M., Petrik, D., Lawler, J., & Petrik, J. (2021) · Cancers · doi:10.3390/cancers13174444 · Cited by 128
HIV infection and latency induce a unique metabolic signature in human macrophages
Castellano, P., Prevedel, L., Valdebenito, S., & Eugenín, E. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-39898-5 · Cited by 117
Lactate in the tumor microenvironment: A rising star for targeted tumor therapy
Li, Z., Wang, Q., Huang, X., Yang, M., Zhou, S., Li, Z., Fang, Z., Tang, Y., Chen, Q., Hou, H., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1113739 · Cited by 118
Cancer heterogeneity is not compatible with one unique cancer cell metabolic map
Strickaert, A., Saiselet, M., Dom, G., Deken, X. D., Dumont, J. E., Féron, O., Sonveaux, P., & Maenhaut, C. (2016) · Oncogene · doi:10.1038/onc.2016.411 · Cited by 111
Self-citationTargeting Glutamine Addiction in Gliomas
Obara‐Michlewska, M., & Szeliga, M. (2020) · Cancers · doi:10.3390/cancers12020310 · Cited by 106
MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming
Liu, Y., Lu, L., Wen, D., Liu, D., Dong, L., Gao, D., Bian, X., Zhou, J., Fan, J., & Wu, W. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0841-3 · Cited by 103
Lactate and lactylation: Behind the development of tumors
Dai, E., Wang, W., Li, Y., Ye, D., & Li, Y. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216896 · Cited by 102
Metabolic Footprints and Molecular Subtypes in Breast Cancer
Cappelletti, V., Iorio, E., Miodini, P., Silvestri, M., Dugo, M., & Daidone, M. G. (2017) · Disease Markers · doi:10.1155/2017/7687851 · Cited by 99
Targeting lactate-related cell cycle activities for cancer therapy
Lin, J. L., Liu, G., Chen, L., Kwok, H. F., & Lin, Y. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.009 · Cited by 101
Metabolic Profiling of healthy and cancerous tissues in 2D and 3D
Russell, S., Wojtkowiak, J. W., Neilson, A., & Gillies, R. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-15325-5 · Cited by 98
Glutamine addiction in tumor cell: oncogene regulation and clinical treatment
Li, X., Peng, X., Li, Y., Wei, S., He, G., Liu, J., Li, X., Yang, S., Dai, L., Lin, W., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01449-x · Cited by 103
Kozlov, A. M., Lone, A., Betts, D. H., & Cumming, R. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-65193-9 · Cited by 94
Carbon Nitride Dots: A Selective Bioimaging Nanomaterial
Liyanage, P. Y., Graham, R. M., Pandey, R. R., Chusuei, C. C., Mintz, K. J., Zhou, Y., Harper, J. K., Wu, W., Wikramanayake, A. H., Vanni, S., et al. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00784 · Cited by 89
Cilingir, E. K., Seven, E. S., Zhou, Y., Walters, B. M., Mintz, K. J., Pandey, R. R., Wikramanayake, A. H., Chusuei, C. C., Vanni, S., Graham, R. M., et al. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.02.058 · Cited by 91
Glutaminase in microglia: A novel regulator of neuroinflammation
Ding, L., Xu, X., Li, C., Wang, Y., Xia, X., & Zheng, J. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.11.038 · Cited by 91
Jiang, H., Zhang, N., Tang, T., Feng, F., Sun, H., & Qu, W. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104844 · Cited by 92
Metabolic tricks of cancer cells
Hönigová, K., Navrátil, J., Peltanová, B., Polanska, H. H., Raudenská, M., & Masařík, M. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188705 · Cited by 84
Zhao, C., Dong, H., Zhang, Y., & Li, Y. (2019) · npj Biofilms and Microbiomes · doi:10.1038/s41522-019-0092-7 · Cited by 80
Lactate induces osteoblast differentiation by stabilization of HIF1α
Wu, Y., Wang, M., Feng, H., Peng, Y., Sun, J., Qu, X., & Li, C. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.05.017 · Cited by 71
Glycolysis-Derived Compounds From Astrocytes That Modulate Synaptic Communication
Gonçalves, C., Rodrigues, L., Bobermin, L. D., Zanotto, C., Vizuete, A. F. K., Quincozes‐Santos, A., Souza, D. O., & Leite, M. C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01035 · Cited by 72
Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting
Yu, Y.-R., & Ho, P. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13293 · Cited by 66
On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer
Penkert, J., Ripperger, T., Schieck, M., Schlegelberger, B., Steinemann, D., & Illig, T. (2016) · Oncotarget · doi:10.18632/oncotarget.11759 · Cited by 64
Liu, Y., Zhang, X., Gu, W., Su, H., Wang, X., Wang, X., Zhang, J., Xu, M., & Sheng, W. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.05.031 · Cited by 64
Salmina, A. B., Kharitonova, E. V., Gorina, Y. V., Тепляшина, Е. А., Malinovskaya, N. A., Хилажева, Е. Д., Mosiagina, A. I., Morgun, A. V., Shuvaev, А. N., Salmin, V. V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094661 · Cited by 63
Immunometabolism: new insights and lessons from antigen-directed cellular immune responses
Ramalho, R., Rao, M., Zhang, C., Agrati, C., Ippolito, G., Wang, F., Zumla, A. I., & Maeurer, M. J. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00798-w · Cited by 63
Tumor lactic acid: a potential target for cancer therapy
Byun, J. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01431-8 · Cited by 58
Delgir, S., Bastami, M., Ilkhani, K., Safi, A., Seif, F., & Alivand, M. R. (2021) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2021.108366 · Cited by 60
Metabolic regulation in the immune response to cancer
Wu, Q., Yu, X., Li, J., Sun, S., & Tu, Y. (2021) · 癌症：英文版 · doi:10.1002/cac2.12182 · Cited by 57
Zheng, X., Ma, H., Wang, J., Huang, M., Fu, D., Qin, L., & Yin, Q. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101534 · Cited by 59
N-acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages
Menga, A., Favia, M., Spera, I., Vegliante, M. C., Gissi, R., Grassi, A., Laera, L., Campanella, A., Gerbino, A., Carrà, G., et al. (2021) · EMBO Reports · doi:10.15252/embr.202051981 · Cited by 57
Including the mitochondrial metabolism of l-lactate in cancer metabolic reprogramming
Lidia de, B. A. R. I., & Atlante, A. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2831-y · Cited by 52
Immunometabolism: Insights from the Drosophila model
Galenza, A., & Foley, E. (2019) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2019.01.011 · Cited by 52
Targeting of stress response pathways in the prevention and treatment of cancer
Zelenka, J., Koncošová, M., & Ruml, T. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.01.007 · Cited by 50
Regulation of Autophagy via Carbohydrate and Lipid Metabolism in Cancer
Alizadeh, J., Kavoosi, M., Singh, N., Lorzadeh, S., Ravandi, A., Kidane, B., Ahmed, N., Mraiche, F., Mowat, M. R. A., & Ghavami, S. (2023) · Cancers · doi:10.3390/cancers15082195 · Cited by 51
Lactate in Sarcoma Microenvironment: Much More than just a Waste Product
Taddei, M. L., Pietrovito, L., Leo, A., & Chiarugi, P. (2020) · Cells · doi:10.3390/cells9020510 · Cited by 48
Mitochondrial Transport in Glycolysis and Gluconeogenesis: Achievements and Perspectives
Passarella, S., Schurr, A., & Portincasa, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312620 · Cited by 50
Kareva, I. (2019) · Stem Cells · doi:10.1002/stem.3051 · Cited by 50
Lactate: Fueling the fire starter
Certo, M., Marone, G., de Paulis, A., Mauro, C., & Pucino, V. (2019) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1474 · Cited by 50
Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
Xu, Y., He, L., Fu, Q., & Hu, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.759015 · Cited by 51
Lactic acidosis induces resistance to the pan-Akt inhibitor uprosertib in colon cancer cells
Barnes, E., Xu, Y., Benito, A., Herendi, L., Siskos, A., Aboagye, E. O., Nijhuis, A. M., & Keun, H. C. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0777-y · Cited by 49
Novel strategies to improve tumour therapy by targeting the proteins MCT1, MCT4 and LAT1
Wang, Y., Qin, L., Chen, W., Chen, Q., Sun, J., & Wang, G. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113806 · Cited by 45
Bacigalupa, Z. A., & Rathmell, W. K. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.034 · Cited by 47
Metabolic regulation of the bone marrow microenvironment in leukemia
Xu, B., Hu, R., Zhao, L., Chen, T., Chen, J., Hu, Y., Jiang, Y., & Li, Y. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100786 · Cited by 46
Strickaert, A., Corbet, C., Spinette, S. A., Craciun, L., Dom, G., Andry, G., Larsimont, D., Wattiez, R., Dumont, J. E., Féron, O., et al. (2019) · Thyroid · doi:10.1089/thy.2018.0435 · Cited by 43
Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis
Sharma, S., Agnihotri, N., & Kumar, S. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114943 · Cited by 42
The Adaptive Complexity of Cancer
Derbal, Y. (2018) · BioMed Research International · doi:10.1155/2018/5837235 · Cited by 41
Lactate Metabolism and Signaling in Tuberculosis and Cancer: A Comparative Review
Kiran, D., & Basaraba, R. J. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.624607 · Cited by 39
Lactate stimulates CA IX expression in normoxic cancer cells
Pánisová, E., Kery, M., Sedlakova, O., Brisson, L., Debreova, M., Sboarina, M., Sonveaux, P., Pastoreková, S., & Švastová, E. (2017) · Oncotarget · doi:10.18632/oncotarget.20836 · Cited by 41
Self-citationDuan, Q., Zhang, S., Wang, Y., Lu, D., Sun, Y., & Wu, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1069555 · Cited by 40
Liu, M., Wang, J., Qi, Q., Huang, B., Chen, A., Li, X., & Wang, J. (2016) · Oncology Reports · doi:10.3892/or.2016.4998 · Cited by 38
Gore, M., Kabekkodu, S. P., & Chakrabarty, S. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189292 · Cited by 41
Revisiting the biological role of the Warburg effect: Evolving perspectives on cancer metabolism
León-Oliva, D. D., González-Prieto, P., Castro-Martinez, P. D., Boaru, D. L., Hernandez, P. L., Fraile‐Μartinez, O., Montero, C. G., Guijarro, L. G., López-González, L., Díaz, R., et al. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156151 · Cited by 42
Targeting MYC Dependence by Metabolic Inhibitors in Cancer
Sabnis, H. S., Somasagara, R. R., & Bunting, K. D. (2017) · Genes · doi:10.3390/genes8040114 · Cited by 36
Daverio, Z., Balcerczyk, A., Rautureau, G. J. P., & Panthu, B. (2023) · Cancers · doi:10.3390/cancers15051417 · Cited by 35
Lactate at the crossroads of tumor metabolism and immune escape: a new frontier in cancer therapy
Dong, Z., Yuan, Z., Jin, T., Gao, C., Wang, X., & Xu, F. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07272-x · Cited by 34
Luo, M., Zhu, J., Ren, J., Tong, Y., Wang, L., Ma, S., & Wang, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1036543 · Cited by 36
A critical review of the role of M2PYK in the Warburg effect
Harris, R. A., & Fenton, A. W. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.01.004 · Cited by 32
Niu, N., Ye, J., Hu, Z., Zhang, J., & Wang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087076 · Cited by 34
Metadata
- Authors
- Pérez-Escuredo, J., Dadhich, R. K., Dhup, S., Cacace, A., Van Hée, V. F., De Saedeleer, C. J., Sboarina, M., Rodriguez, F., Fontenille, M.-J., Brisson, L., Porporato, P. E., & Sonveaux, P.
- Affiliations
- From the Pole of Pharmacology, Institute of Experimental and Clinical Research (IREC), Université catholique de Louvain (UCL) Medical School, Brussels, Belgium
- UCLouvain (BE)
- Corresponding author
- Sonveaux, Pierre
- Venue
- Cell Cycle
- Publisher
- Informa UK Limited
- Published
- 2016-01-02
- Volume
- 15
- Issue
- 1
- Pages
- 72-83
- ISSN
- 1538-4101 (ISSN-L)
- 1551-4005
- PMC
- PMC4825768
- OpenAlex
- W2184384535
- Cited by
- 231
- References
- 56
- Citations by year
- 2026: 15 · 2025: 26 · 2024: 27 · 2023: 24 · 2022: 22 · 2021: 27 · 2020: 29 · 2019: 19 · 2018: 11 · 2017: 22 · 2016: 9
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cell Cycle (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Digital Access to Libraries (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- Fonds De La Recherche Scientifique - FNRS
- Belgian Federal Science Policy Office (UP7-03)
- Fonds Joseph Maisin
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- lactate metabolism, glutamine uptake, glutaminolysis, MCT1, HIF-2α, c-Myc, ASCT2, GLS1, cancer metabolism, metabolic plasticity, lactate signaling, glycolysis
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Monocarboxylate Transport Protein 1, Animals, Glutaminase, Glutamine, HeLa Cells, Humans, Male, Mice, Inbred BALB C, Mice, Nude, Neoplasms, Oxidation-Reduction, Lactic Acid, Monocarboxylic Acid Transporters, Symporters, Mice, Basic Helix-Loop-Helix Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
